Sunshine Biopharma Inc. — Investor Relations & Filings
Filings indexed
382
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
SBFM
Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-05-29 | English | |
| CURRENT REPORT | 2026-05-19 | English | |
| PROSPECTUS | 2026-05-19 | English | |
| 10-Q - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-05-13 | English | |
| 8-K - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-04-09 | English | |
| 10-K - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-04-03 | English |
Browse filings by year
20 years- 2026 8 filings
- 2025 31 filings
- 2024 53 filings
- 2023 33 filings
- 2022 46 filings
- 2021 17 filings
- 2020 20 filings
- 2019 19 filings
- 2018 19 filings
- 2017 11 filings
- 2016 21 filings
- 2015 15 filings
- 2014 16 filings
- 2013 7 filings
- 2012 13 filings
- 2011 7 filings
- 2010 15 filings
- 2009 12 filings
- 2008 12 filings
- 2007 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 47893739 | CURRENT REPORT | 2026-05-29 | English | ||
| 46556164 | CURRENT REPORT | 2026-05-19 | English | ||
| 46545511 | PROSPECTUS | 2026-05-19 | English | ||
| 45762240 | 10-Q - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-05-13 | English | ||
| 33935467 | 8-K - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-04-09 | English | ||
| 33280558 | 10-K - Sunshine Biopharma Inc. (0001402328) (Filer) | 2026-04-03 | English | ||
| 32891318 | 8-K - SUNSHINE BIOPHARMA INC. (0001402328) (Filer) | 2026-02-20 | English | ||
| 32891319 | 8-K - SUNSHINE BIOPHARMA INC. (0001402328) (Filer) | 2026-02-05 | English | ||
|
2025
7 filings
| |||||
| 12165497 | FORM 8-K | 2025-12-12 | English | ||
| 12165498 | FORM 10-Q FOR SEP 2025 | 2025-11-13 | English | ||
| 12165499 | FORM DEFA 14A | 2025-10-23 | English | ||
| 12165500 | DEFINITIVE PROXY | 2025-10-23 | English | ||
| 12165501 | CURRENT REPORT | 2025-09-30 | English | ||
| 12165502 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 12165504 | Regulatory Filings 2025 | 2025-08-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Sunshine Biopharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35352/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35352 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35352 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35352 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35352}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sunshine Biopharma Inc. (id: 35352)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.